Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)
Crossref DOI link: https://doi.org/10.1007/s00394-017-1548-2
Published Online: 2017-10-20
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Monti, Lucilla D.
Galluccio, Elena
Villa, Valentina
Fontana, Barbara
Spadoni, Serena
Piatti, Pier Marco
Funding for this research was provided by:
Italian Ministry of Health (Finalizzata no. 88, 2004)
Text and Data Mining valid from 2017-10-20